15 Jul 2024
// PRESS RELEASE
24 Jun 2024
// PRESS RELEASE
10 May 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Reset all filters
01 2ACITRETIN
02 4ADALIMUMAB
03 1ANTAZOLINE PHOSPHATE
04 3ATOGEPANT
05 1BERACTANT
06 1BEZAFIBRATE
07 2BIMATOPROST
08 3BRIMONIDINE TARTRATE
09 1CARBIDOPA (CARBIDOPA MONOHYDRATE)
10 9CARBOXYMETHYLCELLULOSE SODIUM
11 4CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE)
12 2CYCLOSPORINE
13 1DEOXYCHOLIC ACID
14 1DEXAMETHASONE
15 2ELAGOLIX (ELAGOLIX SODIUM)
16 2ELUXADOLINE
17 2EPCORITAMAB
18 2ETHINYL ESTRADIOL
19 1FLUOROMETHOLONE
20 1FOSCARBIDOPA
21 1FOSLEVODOPA
22 1GATIFLOXACIN
23 2GLECAPREVIR
24 4GLYCERINE
25 2KETOROLAC TROMETHAMINE
26 5LEUPROLIDE ACETATE
27 1LEVODOPA
28 4LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)
29 3LINACLOTIDE
30 3LOPINAVIR
31 5MESALAZINE
32 1MINERAL OIL
33 2NAPHAZOLINE HYDROCHLORIDE
34 4NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
35 1NORETHINDRONE ACETATE
36 2OCTINOXATE
37 2OCTISALATE
38 1OFLOXACIN
39 4ONABOTULINUMTOXINA
40 2PIBRENTASVIR
41 2POLYSORBATE 80
42 1POLYVINYL ALCOHOL
43 1PREDNISOLONE ACETATE
44 5RISANKIZUMAB
45 3RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
46 4RITONAVIR
47 1SEVOFLURANE
48 2SUCRALFATE
49 1TIMOLOL (TIMOLOL MALEATE)
50 1TITANIUM DIOXIDE
51 2UBROGEPANT
52 3UPADACITINIB
53 6VENETOCLAX
54 3VILAZODONE HYDROCHLORIDE
55 1WHITE PETROLATUM
56 2ZINC OXIDE
Reset all filters
01 9CAPSULE
02 4CAPSULE (EXTENDED RELEASE)
03 5DROPS
04 5EMULSION
05 2GEL
06 2GRANULES
07 1IMPLANT
08 1LIQUID
09 7LOTION
10 2OINTMENT
11 4POWDER FOR SOLUTION
12 5POWDER FOR SUSPENSION, SUSTAINED-RELEASE
13 37SOLUTION
14 2SUPPOSITORY
15 6SUSPENSION
16 35TABLET
17 2TABLET (DELAYED-RELEASE)
18 4TABLET (EXTENDED-RELEASE)
Reset all filters
01 10.01%/W/V
02 10.03%/W/V
03 20.05%/W/V
04 10.051%
05 20.1%/W/V
06 10.15%/W/V
07 20.2%/W/V
08 20.3%/W/V
09 10.45%/W/V
10 20.5%
11 60.5%/W/V
12 20.5%/W/W
13 10.51%
14 10.7MG
15 20.9%/W/V
16 11%
17 41%/W/V
18 11%/W/W
19 11.4%/W/V
20 11.5MG
21 11000MG
22 7100MG
23 1100MG/5ML
24 2100UNIT/VIAL
25 210MCG
26 610MG
27 110MG/ML
28 111.25MG/SYR
29 1120MG
30 112MG/ML
31 1145MCG
32 2150MG
33 2150MG/1ML
34 115MG
35 1180MG/1.2ML
36 11G
37 11G/5ML
38 11MG
39 12.5MG
40 2200MG
41 1200UNIT/VIAL
42 320MG
43 120MG/0.2ML
44 120MG/ML
45 120MG/SACHET
46 122.5MG/SYR
47 1240MG/ML
48 225MG
49 125MG/ML
50 1290MCG
51 12G/60G
52 23%/W/W
53 13.5%/W/W
54 13.75MG/SYR
55 230MG
56 130MG/SYR
57 235MG
58 1360MG/2.4ML
59 13MG
60 14.5MG
61 1400MG
62 1400MG/5ML
63 340MG
64 240MG/0.4ML
65 140MG/0.8ML
66 142.5%
67 145MG
68 14G/60G
69 2500MG
70 450MG
71 150MG/SACHET
72 150UNIT/VIAL
73 157.3%
74 15MG
75 25MG/ML
76 160MG
77 260MG/ML
78 16MG
79 27.5%/W/W
80 17.5MG/SYR
81 172MCG
82 175MG
83 28%/W/W
84 180MG
85 199.97%
Reset all filters
01 2ACTONEL
02 1ACTONEL DR
03 1ACULAR
04 1ACUVAIL
05 1ALBALON
06 1ALPHAGAN
07 1ALPHAGAN P
08 1BELKYRA
09 1BEZALIP SR
10 3BOTOX
11 1BOTOX COSMETIC
12 4BYSTOLIC
13 2COMBIGAN
14 3CONSTELLA
15 2DUODOPA
16 2EPKINLY
17 4FETZIMA
18 1FML
19 4HUMIRA
20 6KALETRA
21 1LATISSE
22 3LOLO
23 1LUMIGAN RC
24 5LUPRON DEPOT
25 4MAVIRET
26 1NORVIR
27 1OCUFLOX
28 2ORILISSA
29 1OZURDEX
30 1PRED FORTE
31 3QULIPTA
32 1REFRESH
33 1REFRESH CELLUVISC
34 1REFRESH CONTACTS
35 2REFRESH EYE ALLERGY RELIEF
36 2REFRESH LACRI-LUBE
37 1REFRESH LIQUIGEL
38 3REFRESH OPTIVE ADVANCED
39 3REFRESH OPTIVE ADVANCED SENSITIVE
40 2REFRESH OPTIVE FUSION
41 2REFRESH OPTIVE GEL DROPS
42 1REFRESH PLUS
43 1REFRESH TEARS
44 1RESTASIS
45 1RESTASIS MULTIDOSE
46 3RINVOQ
47 5SALOFALK
48 1SEVORANE AF
49 5SKYRIZI
50 2SORIATANE
51 1SULCRATE
52 1SULCRATE SUSPENSION PLUS
53 1SURVANTA
54 3TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN
55 4TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN TINTED
56 2UBRELVY
57 6VENCLEXTA
58 2VIBERZI
59 3VIIBRYD
60 4VRAYLAR
61 2VYALEV
62 1ZYMAR
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging : 30
Brand Name : SORIATANE
Approval Date :
Application Number : 2070863
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 10MG
Packaging : 30
Brand Name : SORIATANE
Approval Date :
Application Number : 2070847
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 40MG/0.8ML
Packaging :
Brand Name : HUMIRA
Approval Date :
Application Number : 2258595
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 0.51%
Packaging : 15ML
Brand Name : REFRESH EYE ALLERGY RELIEF
Approval Date :
Application Number : 2315890
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 40MG/0.4ML
Packaging : 0.4ML
Brand Name : HUMIRA
Approval Date :
Application Number : 2458357
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 40MG/0.4ML
Packaging :
Brand Name : HUMIRA
Approval Date :
Application Number : 2458349
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 20MG/0.2ML
Packaging : 0.2ML
Brand Name : HUMIRA
Approval Date :
Application Number : 2474263
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Brand Name : QULIPTA
Approval Date :
Application Number : 2533979
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Brand Name : QULIPTA
Approval Date :
Application Number : 2533987
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 60MG
Packaging :
Brand Name : QULIPTA
Approval Date :
Application Number : 2533995
Regulatory Info : Prescription
Registration Country : Canada